Skip to content

Application of long-acting local anesthetics in laparoscopic inguinal hernia

Application of long-acting local anesthetics in laparoscopic inguinal hernia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113829
Enrollment
Unknown
Registered
2025-12-03
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia

Interventions

Control group: incision infiltration 0.75% ropivacaine 30ml normal saline 10ml. To observe the effectiveness and safety of long-acting local anesthetics after surgery.:incision infiltration 0.75% ropi
The included patients were randomly divided into two groups to complete laparoscopic repair gap free of inguinal hernia, and the experimental group: infiltrated and sprayed with bupivacaine liposomes

Sponsors

Zigong Fourth People's Hospital(Zigong First-aid Center)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male patients with inguinal hernia; 2. Age range: 60-75 years old; 3. ASA classification levels I-II; 4. Patients and their families give informed consent to this study.

Exclusion criteria

Exclusion criteria: 1. Acute incarcerated hernia or refractory hernia; 2. Merge serious underlying diseases; 3. Uncontrolled chronic obstructive pulmonary disease patients; 4. Patients with poor drug control for prostate hyperplasia;

Design outcomes

Primary

MeasureTime frame
Dynamic Visual Analog Scale (VAS) Score and Area Under the Curve;

Secondary

MeasureTime frame
Postoperative recovery quality (QoR-15 scale);Duration and dosage of opioid use;Adverse reaction incidence rate;

Countries

China

Contacts

Public ContactXuefeng Peng

Zigong Fourth People's Hospital(Zigong First-aid Center)

443420030@qq.com+86 813 2207123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026